Menu
GWAS Study

Genome-Wide Association Study of White Blood Cell Counts in Patients With Ischemic Stroke.

Torres-Aguila NP, Carrera C, Giese AK et al.

31587654 PubMed ID
GWAS Study Type
2471 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TN
Torres-Aguila NP
CC
Carrera C
GA
Giese AK
CN
Cullell N
ME
Muiño E
CJ
Cárcel-Márquez J
GC
Gallego-Fabrega C
GJ
González-Sánchez J
DM
Del Mar Freijo M
ÁJ
Álvarez-Sabín J
MC
Molina C
RM
Ribó M
JJ
Jimenez-Conde J
RJ
Roquer J
ST
Sobrino T
CF
Campos F
CJ
Castillo J
ML
Muñoz-Narbona L
LE
Lopez-Cancio E
DA
Dàvalos A
DR
Diaz-Navarro R
TS
Tur S
VC
Vives-Bauza C
SG
Serrano-Heras G
ST
Segura T
KJ
Krupinski J
DR
Delgado-Mederos R
MJ
Martí-Fàbregas J
HL
Heitsch L
IL
Ibañez L
CC
Cruchaga C
RN
Rost NS
MJ
Montaner J
LJ
Lee JM
FI
Fernandez-Cadenas I
Chapter II

Abstract

Summary of the research findings

Background and Purpose- Immune cells play a key role in the first 24h poststroke (acute phase), being associated with stroke outcome. We aimed to find genetic risk factors associated with leukocyte counts during the acute phase of stroke. Methods- Ischemic stroke patients with leukocyte counts data during the first 24h were included. Genome-wide association study and gene expression studies were performed. Results- Our genome-wide association study, which included 2064 (Discovery) and 407 (Replication) patients, revealed a new locus (14q24.3) associated with leukocyte counts. After Joint analysis (n=2471) 5 more polymorphisms reached genome-wide significance (P<5×10-8). The 14q24.3 locus was associated with acute stroke outcome (rs112809786, P=0.036) and with ACOT1 and PTGR2 gene expression. Previous polymorphisms associated with leukocyte counts in general-population did not show any significance in our study. Conclusions- We have found the first locus associated with leukocyte counts in ischemic stroke, also associated with acute outcome. Genetic analysis of acute endophenotypes could be useful to find the genetic factors associated with stroke outcome. Our findings suggested a different modulation of immune cells in stroke compared with healthy conditions.

2,064 Spanish ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

2471
Total Participants
GWAS
Study Type
Yes
Replicated
407 European ancestry individuals
Replication Participants
European
Ancestry
Spain, U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.